There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human CD22. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a modified CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by cells expressing CD22.

 
Web www.patentalert.com

< Peptides for the diagnosis of schizophrenia

> Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

~ 00424